Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence

Vaccine

Volumn 24, Issue 6, 2006, Pages 738-749

  Shen, Tao ^a   Liang, Hua ^a   Tong, Xiao ^a,b   Fan, Xiujuan ^a   He, Xiang ^a   Ma, Yan ^a   Xiang, Wenhua ^c   Shen, Rongxian ^c   Zhang, Xiaoyan ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Attenuated vaccine; EIAV; Mutated infectious clone

Indexed keywords

AMINO ACID; GAG PROTEIN; LIVE VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENVELOPE GENE; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYMPTOMATOLOGY; VACCINE PRODUCTION; VIRULENCE; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS MUTANT; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DISEASE PROGRESSION; DNA PRIMERS; EQUINE INFECTIOUS ANEMIA; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD; VIRAL VACCINES; VIRULENCE;

EID: 31944443862     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.084     Document Type: Article

References (62)

1. M.A. Gonda, M.J. Braun, J.E. Clements, J.M. Pyper, F. Wong-Staal, and R.C. Gallo Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses Proc Natl Acad Sci USA 83 11 1986 4007 4011
2. J.E. Clements, and M.C. Zink Molecular biology and paihogenesis of animal lentivirus infections Clin Microbiol Rev 9 1 1996 100 117
3. I. Hotzel Conservation of the human immunodeficiency virus type 1 gpl20 V1/V2 stem/loop structure in the equine infectious anemia virus (EIAV) gp90 AIDS Res Hum Retroviruses 19 10 2003 923 924
4. R.J. Miller, J.S. Cairns, S. Bridges, and N. Sarver Human immunodeficiency virus and AIDS: insights from animal lentiviruses J Virol 74 16 2000 7187 7195
5. T.C. McGuire, K.I. O'Rourke, and L.E. Perryman Immunopathogenesis of equine infectious anemia lentivirus disease Dev Biol Stand 1990 7231 7237
6. H. Tang, K.L. Kuhen, and F. Wong-Staal Lentivirus replication and regulation Annu Rev Genet 1999 33133 33170
7. C.J. Issel, and L. Cog gins Equine infectious anemia: current knowledge J Am Vet Med Assoc 174 7 1979 727 733
8. D.C. Sellon, F.J. Fuller, and T.C. McGuire The immunopathogenesis of equine infectious anemia virus Virus Res 32 2 1994 111 138
9. W.P. Cheevers, and T.C. McGuire Equine infectious anemia virus: immunopathogenesis and persistence Rev Infect Dis 7 1 1985 83 88
10. S.A. Hammond, S.J. Cook, D.L. Liechtenstein, C.J. Issel, and R.C. Montelaro Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process J Virol 71 5 1997 3840 3852
11. C. Leroux, J.L. Cadore, and R.C. Montelaro Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us? Vet Res 35 4 2004 485 512
12. Shen, R-X, Wang Z. Development and use of an equine infectious anemia donkey leucocyte attenuated vaccine. EIAV: a national review of policies, programs, and future objectives. Amarillo, TX: American Quarter Horse Association; 1985.
13. R.X. Shen, Z.D. Xu, X.S. He, and S.X. Zhang Study on immunological methods of equine infectious anemia China Agric. Sci. 1979 41 115
14. Shen RX, Wang ZY, Dong JP, Peng DC, Jia B, Lv XL, et al. Fetal donkey dermal cells adapted attenuated vaccine of equine infectious anemia virus and its culture method (Chinese patent No. 01123620). China, 2001.
15. L.R. Costa, I.K. Santos, C.J. Issel, and R.C. Montelaro Tumor necrosis factor-alpha production and disease severity after immunization with enriched major core protein (p26) and/or infection with equine infectious anemia virus Vet Immunol Immunopathol 57 1-2 1997 33 47
16. J.M. Ball, C.L. Swaggerty, X. Pei, W.S. Lim, X. Xu, and V.C. Cox SU proteins from virulent and avirulent EIAV demonstrate distinct biological properties Virology 333 1 2005 132 144
17. S.L. Payne, X.F. Pei, B. Jia, A. Fagerness, and F.J. Fuller Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus J Virol 78 5 2004 2478 2485
18. K. O'Rourke, L.E. Perryman, and T.C. McGuire Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus J Gen Virol 69 Pt 3 1988 667 674
19. T.C. McGuire, S.R. Leib, R.H. Mealey, D.G. Fraser, and D.J. Prieur Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule J Immunol 171 4 2003 1984 1993
20. J.M. Ball, K.E. Rushlow, C.J. Issel, and R.C. Montelaro Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies J Virol 66 2 1992 732 742
21. C. Leroux, C.J. Issel, and R.C. Montelaro Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony J Virol 71 12 1997 9627 9639
22. C. Leroux, J.K. Craigo, C.J. Issel, and R.C. Montelaro Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies J Virol 75 10 2001 4570 4583
23. M.R. Raabe, C.J. Issel, and R.C. Montelaro Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus J Virol Methods 71 1 1998 87 104
24. He Xiang, SYM, Xue Fei, Fan Xie Juan, Shen Rong Xian. Construction of infectious chimeric clones of equine infectious anemia virus (EIAV). Chin. J. Virol. 2003:19128-19132.
25. L. Cog gins, N.L. Norcross, and S.R. Nusbaum Diagnosis of equine infectious anemia by immunodiffusion test Am J Vet Res 33 1 1972 11 18
26. S.A. Hammond, F. Li, B.M. McKeon Sr., S.J. Cook, C.J. Issel, and R.C. Montelaro Immune responses and viral replication in long-term inapparent carrier ponies inoculated wilh equine infectious anemia virus J Virol 74 13 2000 5968 5981
27. S.Z. Wang, K.E. Rushlow, C.J. Issel, R.F. Cook, S.J. Cook, and M.L. Raabe Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein Virology 199 1 1994 247 251
28. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1 1989 51 59
29. D. Gheysen, E. Jacobs, F. de Foresta, C. Thiriart, M. Francotte, and D. Thines Assembly and release of FflV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells Cell 59 1 1989 103 112
30. T. Dorfman, F. Mammano, W.A. Haseltine, and H.G. Gottlinger Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein J Virol 68 3 1994 1689 1696
31. E.O. Freed, and M.A. Martin HIV-1 infection of non-dividing cells Nature 369 6476 1994 107 108
32. M.I. Bukrinsky, S. Haggerty, M.P. Dempsey, N. Sharova, A. Adzhubel, and L. Spitz A nuclear localization signal wilhin HIV-1 matrix protein that governs infection of non-dividing cells Nature 365 6447 1993 666 669
33. M. Bryant, and L. Ratner Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 Proc Natl Acad Sci USA 87 2 1990 523 527
34. L.E. Henderson, R.C. Sowder, G.W. Smytiiers, and S. Oroszlan Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins J Virol 61 4 1987 1116 1124
35. W. Zhou, and M.D. Resh Differential membrane binding of the human immunodeficiency virus type 1 matrix protein J Virol 70 12 1996 8540 8548
36. S.D. Fuller, T. Wilk, B.E. Gowen, H.G. Krausslich, and V.M. Vogt Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle Curr Biol 7 10 1997 729 738
37. T. Wilk, I. Gross, B.E. Gowen, T. Rutten, F. de Haas, and R. Welker Organization of immature human immunodeficiency virus type 1 J Virol 75 2 2001 759 771
38. H. Reil, A.A. Bukovsky, H.R. Gelderblom, and H.G. Gottlinger Efficient HIV-1 replication can occur in the absence of the viral matrix protein EMBO J 17 9 1998 2699 2708
39. H. Hatanaka, O. Iourin, Z. Rao, E. Fry, A. Kingsman, and D.I. Stuart Structure of equine infectious anemia virus matrix protein J Virol 76 4 2002 1876 1883
40. C. Chen, F. Li, and R.C. Montelaro Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection J Virol 75 20 2001 9762 9770
41. B.A. Puffer, L.J. Parent, J.W. Wills, and R.C. Montelaro Equine infectious anemia virus utilizes a YXXL motif wilhin the late assembly domain of the Gag p9 protein J Virol 71 9 1997 6541 6546
42. S. Peters, M. Munoz, S. Yerly, V. Sanchez-Merino, C. Lopez-Galindez, and L. Perrin Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein J Virol 75 20 2001 9644 9653
43. J.C. Kappes, J.S. Parkin, J.A. Conway, J. Kim, C.G. Brouillette, and G.M. Shaw Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components Virology 193 1 1993 222 233
44. C. Lavallee, X.J. Yao, A. Ladha, H. Gottlinger, W.A. Haseltine, and E.A. Cohen Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles J Virol 68 3 1994 1926 1934
45. W. Paxton, R.I. Connor, and N.R. Landau Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis J Virol 67 12 1993 7229 7237
46. E. Kondo, and H.G. Gottlinger A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr J Virol 70 1 1996 159 164
47. T.M. Fletcher 3rd, B. Brichacek, N. Sharova, M.A. Newman, G. Stivahtis, and P.M. Sharp Nuclear import and cell cycle arrest functions of the FflV-1 Vpr protein are encoded by two separate genes in FflV-2/SIV(SM) Embo J 15 22 1996 6155 6165
48. F. Li, C. Leroux, J.K. Craigo, S.J. Cook, C.J. Issel, and R.C. Montelaro The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies J Virol 74 1 2000 573 579
49. D.L. Liechtenstein, C.J. Issel, and R.C. Montelaro Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected wilh equine infectious anemia virus J Virol 70 6 1996 3346 3354
50. H. Pang, X.G. Kong, H. Sentsui, Y. Kono, T. Sugiura, and A. Hasegawa Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse J Vet Med Sci 59 12 1997 1089 1095
51. Y.H. Zheng, H. Sentsui, Y. Kono, and K. Ikuta Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages Virus Res 68 1 2000 93 98
52. Y.H. Zheng, T. Nakaya, H. Sentsui, M. Kameoka, M. Kishi, and K. Hagiwara Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse J Gen Virol 78 Pt 4 1997 807 820
53. B. Chackerian, L.M. Rudensey, and J. Overbaugh Specific N-linked and O-linked glycosylation modifications in the envelope VI domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies J Virol 71 10 1997 7719 7727
54. C.A. Pikora Glycosylation of the ENV spike of primate immunodeficiency viruses and antibody neutralization Curr HIV Res 2 3 2004 243 254
55. P.D. Kwong, R. Wyatt, E. Desjardins, J. Robinson, J.S. Culp, and B.D. Hellmig Probability analysis of variational crystallization and its application to gpl20, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1) J Biol Chem 274 7 1999 4115 4123
56. R.F. Cook, S.L. Berger, K.E. Rushlow, J.M. McManus, S.J. Cook, and S. Harrold Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein J Virol 69 3 1995 1493 1499
57. R.R. Garrity, G. Rimmelzwaan, A. Mnassian, W.P. Tsai, G. Lin, and J.J. de Jong Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope J Immunol 159 1 1997 279 289
58. C.J. Issel, D.W. Horohov, D.F. Lea, W.V. Adams Jr., S.D. Hagius, and J.M. McManus Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus J Virol 66 6 1992 3398 3408
59. M.D. Daniel, R. Kirchhoff, S.C. Czajak, P.K. Sehgal, and R.C. Desrosiers Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene Science 258 5090 1992 1938 1941
60. J.S. Gibbs, D.A. Regier, and R.C. Desrosiers Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes AIDS Res Hum Retroviruses 10 5 1994 607 616
61. T.W. Baba, V. Liska, A.H. Khimani, N.B. Ray, P.J. Dailey, and D. Penninck Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques Nat Med 5 2 1999 194 203
62. R. Hofmann-Lehmann, J. Vlasak, A.L. Williams, A.L. Chenine, H.M. McClure, and D.C. Anderson Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation Aids 17 2 2003 157 166